PFIZER INC shareholders Q2 2022

PFIZER INC's ticker is PFE and the CUSIP is 717081103. A total of 3,117 filers reported holding PFIZER INC in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.7%.

PFIZER INC shareholders Q2 2022
Name	Shares	Value	Weighting ↓
Oder Investment Management, LLC	52,133	$2,733,000	3.36%
Cyrus J. Lawrence, LLC	217,606	$11,409,000	3.29%
Signet Investment Advisory Group, Inc.	90,474	$4,744,000	3.29%
STRATEGY ASSET MANAGERS LLC	201,789	$10,580,000	3.26%
Stillwater Capital Advisors, LLC	331,460	$17,378,000	3.23%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC	202,244	$10,604,000	3.23%
WAFRA INC.	1,617,197	$84,790,000	3.23%
Rhenman & Partners Asset Management AB	540,000	$28,312,000	3.22%
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO	53,568,997	$2,808,623,000	3.21%
Edge Wealth Management LLC	282,310	$14,802,000	3.20%
BIRMINGHAM CAPITAL MANAGEMENT CO INC/AL	152,946	$8,019,000	3.20%
Keene & Associates, Inc.	64,930	$3,404,000	3.19%
Monte Financial Group, LLC	104,038	$5,455,000	3.18%
Knott David M Jr	143,500	$7,524,000	3.16%
MEYER HANDELMAN CO	1,400,579	$73,433,000	3.15%
Sabal Trust CO	832,312	$43,638,000	3.13%
Barry Investment Advisors, LLC	199,032	$10,435,000	3.13%
Capitol Family Office, Inc.	57,661	$3,023,000	3.11%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC	464,928	$18,207,000	3.10%
UNITED FIRE GROUP INC	95,000	$4,981,000	3.05%

About PFIZER INC

Pfizer Inc. is a global pharmaceutical company that has been in operation for over 170 years. The company is headquartered in New York City and has a presence in over 150 countries worldwide. Pfizer is known for its innovative research and development of drugs that have helped to improve the lives of millions of people around the world.

One of Pfizer's most well-known products is Viagra, a drug used to treat erectile dysfunction. However, the company has a much broader portfolio of products that includes treatments for cancer, cardiovascular disease, and rare diseases. Pfizer has also been at the forefront of the fight against COVID-19, developing a vaccine that has been authorized for emergency use in many countries.

Pfizer's success can be attributed to its commitment to research and development. The company invests heavily in R&D, with over $8 billion spent in 2020 alone. This investment has led to the development of many groundbreaking drugs, including Lipitor, the best-selling drug of all time.

Despite its success, Pfizer faces challenges in the form of competition from other pharmaceutical companies and the ongoing COVID-19 pandemic. However, the company's strong financial position and commitment to innovation make it well-positioned to continue to thrive in the years to come.

In conclusion, Pfizer Inc. is a global pharmaceutical company that has been at the forefront of drug development for over 170 years. The company's commitment to research and development has led to the development of many groundbreaking drugs, and its recent success in the fight against COVID-19 has further cemented its position as a leader in the industry.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists PFIZER INC's shareholders in Q2 2022. To view PFIZER INC's shareholder history, click here.